EU invests $5.4 million in Grindeks's new facility
This article was originally published in Scrip
Executive Summary
Grindeks of Latvia has signed an agreement with the national investment and development agency, under which it will receive funding of Ls2.8 million ($5.4 million) from the European Regional Development Fund to build a new 1,400 m2 plant for the production of ursodeoxycholic acid (UDCA).